Merdad Parsey, Chief Medical Officer at GILEAD SCIENCES INC (GILD), sold 182 shares at $68.32 ($12K) on 2020-08-17, disclosed to the SEC on 2020-08-19.
Scheduled sale ($12k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| GILD | SELL | 2024-10-02 | $168K | — | Filing → |
| GILD | SELL | 2024-09-13 | $1.8M | — | Filing → |
| GILD | SELL | 2024-07-01 | $137K | — | Filing → |